MovDisordV3, PascalFrancis, Curation, bibRecord, 003852

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine

Identifieur interne : 003852 ( PascalFrancis/Curation ); précédent : 003851; suivant : 003853

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine

Auteurs : M. Gassen [Allemagne] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]

Source :

Movement disorders [ 0885-3185 ] ; 1998.

RBID : Pascal:98-0354349

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Phéochromocytome, Culture cellulaire, Apomorphine, Antioxydant, Agoniste, Récepteur dopaminergique D2, Récepteur dopaminergique D1, Neuroprotecteur, Radical libre, Stress oxydatif, Activité biologique, Mécanisme action, In vitro, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Agonist, Antioxidant, Biological activity, Cell culture, D1 Dopamine receptor, D2 Dopamine receptor, Free radical, Human, In vitro, Mechanism of action, Neuroprotective agent, Oxidative stress, Parkinson disease, Pheochromocytoma.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 13`
A06				`@2 4`
A08	`01`	`1`	`ENG`	`@1 Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H₂O₂ and 6-hydroxydopamine`
A11	`01`	`1`		`@1 GASSEN (M.)`
A11	`02`	`1`		`@1 GROSS (A.)`
A11	`03`	`1`		`@1 YOUDIM (M. B. H.)`
A14	`01`			`@1 Merck KGaA, Biomedical Research CNS @2 Darmstadt @3 DEU @Z 1 aut.`
A14	`02`			`@1 Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion @2 Haifa @3 ISR @Z 2 aut. @Z 3 aut.`
A20				`@1 661-667`
A21				`@1 1998`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000077139450070`
A44				`@0 0000 @1 © 1998 INIST-CNRS. All rights reserved.`
A45				`@0 27 ref.`
A47	`01`	`1`		`@0 98-0354349`
A60				`@1 P`
A61				`@0 A`
A64		`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B02B06`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Phéochromocytome @5 04`
C03	`02`	`X`	`ENG`	`@0 Pheochromocytoma @5 04`
C03	`02`	`X`	`SPA`	`@0 Feocromocitoma @5 04`
C03	`03`	`X`	`FRE`	`@0 Culture cellulaire @5 05`
C03	`03`	`X`	`ENG`	`@0 Cell culture @5 05`
C03	`03`	`X`	`SPA`	`@0 Cultivo celular @5 05`
C03	`04`	`X`	`FRE`	`@0 Apomorphine @2 NK @2 FR @5 07`
C03	`05`	`X`	`FRE`	`@0 Antioxydant @5 08`
C03	`05`	`X`	`ENG`	`@0 Antioxidant @5 08`
C03	`05`	`X`	`SPA`	`@0 Antioxidante @5 08`
C03	`06`	`X`	`FRE`	`@0 Agoniste @5 09`
C03	`06`	`X`	`ENG`	`@0 Agonist @5 09`
C03	`06`	`X`	`SPA`	`@0 Agonista @5 09`
C03	`07`	`X`	`FRE`	`@0 Récepteur dopaminergique D2 @5 10`
C03	`07`	`X`	`ENG`	`@0 D2 Dopamine receptor @5 10 @6 «D2» Dopamine receptor`
C03	`07`	`X`	`SPA`	`@0 Receptor dopaminérgico D2 @5 10`
C03	`08`	`X`	`FRE`	`@0 Récepteur dopaminergique D1 @5 11`
C03	`08`	`X`	`ENG`	`@0 D1 Dopamine receptor @5 11 @6 «D1» Dopamine receptor`
C03	`08`	`X`	`SPA`	`@0 Receptor dopaminérgico D1 @5 11`
C03	`09`	`X`	`FRE`	`@0 Neuroprotecteur @5 12`
C03	`09`	`X`	`ENG`	`@0 Neuroprotective agent @5 12`
C03	`09`	`X`	`SPA`	`@0 Neuroprotector @5 12`
C03	`10`	`X`	`FRE`	`@0 Radical libre @2 FX @5 13`
C03	`10`	`X`	`ENG`	`@0 Free radical @2 FX @5 13`
C03	`10`	`X`	`SPA`	`@0 Radical libre @2 FX @5 13`
C03	`11`	`X`	`FRE`	`@0 Stress oxydatif @5 14`
C03	`11`	`X`	`ENG`	`@0 Oxidative stress @5 14`
C03	`11`	`X`	`SPA`	`@0 Stress oxidativo @5 14`
C03	`12`	`X`	`FRE`	`@0 Activité biologique @5 17`
C03	`12`	`X`	`ENG`	`@0 Biological activity @5 17`
C03	`12`	`X`	`SPA`	`@0 Actividad biológica @5 17`
C03	`13`	`X`	`FRE`	`@0 Mécanisme action @5 18`
C03	`13`	`X`	`ENG`	`@0 Mechanism of action @5 18`
C03	`13`	`X`	`SPA`	`@0 Mecanismo acción @5 18`
C03	`14`	`X`	`FRE`	`@0 In vitro @5 19`
C03	`14`	`X`	`ENG`	`@0 In vitro @5 19`
C03	`14`	`X`	`SPA`	`@0 In vitro @5 19`
C03	`15`	`X`	`FRE`	`@0 Homme @5 20`
C03	`15`	`X`	`ENG`	`@0 Human @5 20`
C03	`15`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`06`	`X`	`FRE`	`@0 Endocrinopathie @5 45`
C07	`06`	`X`	`ENG`	`@0 Endocrinopathy @5 45`
C07	`06`	`X`	`SPA`	`@0 Endocrinopatía @5 45`
C07	`07`	`X`	`FRE`	`@0 Tumeur sécrétante @5 46`
C07	`07`	`X`	`ENG`	`@0 Secretory tumor @5 46`
C07	`07`	`X`	`SPA`	`@0 Tumor secretante @5 46`
N21				`@1 236`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002F72

Links to Exploration step

Pascal:98-0354349

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H<sub>2</sub>
O<sub>2</sub>
 and 6-hydroxydopamine</title>
<author><name sortKey="Gassen, M" sort="Gassen, M" uniqKey="Gassen M" first="M." last="Gassen">M. Gassen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Merck KGaA, Biomedical Research CNS</s1>
<s2>Darmstadt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Gross, A" sort="Gross, A" uniqKey="Gross A" first="A." last="Gross">A. Gross</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
</affiliation>
</author>
<author><name sortKey="Youdim, M B H" sort="Youdim, M B H" uniqKey="Youdim M" first="M. B. H." last="Youdim">M. B. H. Youdim</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0354349</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0354349 INIST</idno>
<idno type="RBID">Pascal:98-0354349</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002F72</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003852</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H<sub>2</sub>
O<sub>2</sub>
 and 6-hydroxydopamine</title>
<author><name sortKey="Gassen, M" sort="Gassen, M" uniqKey="Gassen M" first="M." last="Gassen">M. Gassen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Merck KGaA, Biomedical Research CNS</s1>
<s2>Darmstadt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Gross, A" sort="Gross, A" uniqKey="Gross A" first="A." last="Gross">A. Gross</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
</affiliation>
</author>
<author><name sortKey="Youdim, M B H" sort="Youdim, M B H" uniqKey="Youdim M" first="M. B. H." last="Youdim">M. B. H. Youdim</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Israël</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Antioxidant</term>
<term>Biological activity</term>
<term>Cell culture</term>
<term>D1 Dopamine receptor</term>
<term>D2 Dopamine receptor</term>
<term>Free radical</term>
<term>Human</term>
<term>In vitro</term>
<term>Mechanism of action</term>
<term>Neuroprotective agent</term>
<term>Oxidative stress</term>
<term>Parkinson disease</term>
<term>Pheochromocytoma</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Phéochromocytome</term>
<term>Culture cellulaire</term>
<term>Apomorphine</term>
<term>Antioxydant</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique D2</term>
<term>Récepteur dopaminergique D1</term>
<term>Neuroprotecteur</term>
<term>Radical libre</term>
<term>Stress oxydatif</term>
<term>Activité biologique</term>
<term>Mécanisme action</term>
<term>In vitro</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>13</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H<sub>2</sub>
O<sub>2</sub>
 and 6-hydroxydopamine</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>GASSEN (M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>GROSS (A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>YOUDIM (M. B. H.)</s1>
</fA11>
<fA14 i1="01"><s1>Merck KGaA, Biomedical Research CNS</s1>
<s2>Darmstadt</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>661-667</s1>
</fA20>
<fA21><s1>1998</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000077139450070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1998 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>27 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>98-0354349</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Phéochromocytome</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Pheochromocytoma</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Feocromocitoma</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Culture cellulaire</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Cell culture</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Cultivo celular</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Antioxydant</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Antioxidant</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Antioxidante</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Agoniste</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Agonist</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Agonista</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0>
<s5>10</s5>
<s6>«D2» Dopamine receptor</s6>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Récepteur dopaminergique D1</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>D1 Dopamine receptor</s0>
<s5>11</s5>
<s6>«D1» Dopamine receptor</s6>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Receptor dopaminérgico D1</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Neuroprotecteur</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Neuroprotective agent</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Neuroprotector</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Radical libre</s0>
<s2>FX</s2>
<s5>13</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Free radical</s0>
<s2>FX</s2>
<s5>13</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Radical libre</s0>
<s2>FX</s2>
<s5>13</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Stress oxydatif</s0>
<s5>14</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Oxidative stress</s0>
<s5>14</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Stress oxidativo</s0>
<s5>14</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Activité biologique</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Biological activity</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Actividad biológica</s0>
<s5>17</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Mécanisme action</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Mechanism of action</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Mecanismo acción</s0>
<s5>18</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>In vitro</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>In vitro</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>In vitro</s0>
<s5>19</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Endocrinopathie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Endocrinopathy</s0>
<s5>45</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Endocrinopatía</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Tumeur sécrétante</s0>
<s5>46</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Secretory tumor</s0>
<s5>46</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Tumor secretante</s0>
<s5>46</s5>
</fC07>
<fN21><s1>236</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003852 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 003852 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:98-0354349
   |texte=   Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine

Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri